Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Porcine respiratory and reproductive syndrome virus
MSD Animal Health UK Limited
QI09AD03
Porcine respiratory and reproductive syndrome virus
Lyophilisate for suspension for injection
POM-V - Prescription Only Medicine – Veterinarian
Pigs
Live Viral Vaccine
Authorized
2000-09-21
Revised: September 2023 AN: 00878/2022 Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Porcilis PRRS lyophilisate and solvent for suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 2 ml (intramuscular injection) or 0.2 ml (intradermal application) of reconstituted vaccine contains: Lyophilisate: ACTIVE SUBSTANCE: Live attenuated PRRS virus strain DV: 10 4.0 - 10 6.3 TCID 50 * * tissue culture infective dose 50 % Solvent: ADJUVANT: dl- -tocopheryl acetate: 75 mg/ml EXCIPIENTS: QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS _Lyophilisate:_ culture medium chemically defined stabiliser CD#279 (patented) _Solvent:_ polysorbate 80 sodium chloride potassium dihydrogen phosphate disodium phosphate dihydrate simethicone water for injection Lyophilisate: light yellow to white cake. Solvent: white solution. Revised: September 2023 AN: 00878/2022 Page 2 of 9 3. CLINICAL INFORMATION 3.1 TARGET SPECIES Pigs. 3.2 INDICATIONS FOR USE FOR EACH TARGET SPECIES For active immunisation of clinically healthy pigs in a PRRS virus contaminated environment, to reduce viraemia caused by infection with European strains of PRRS virus. SPECIFIC CLAIMS For finishing pigs, the effect of the virus on the respiratory system is most relevant. A significant improvement of rearing results (reduced morbidity due to PRRS infection, and a better daily growth and feed conversion) until the end of the fattening period was observed in vaccinated pigs during field trials, particularly in piglets vaccinated at 6 weeks of age. For breeding pigs, the effect of the virus on the reproductive system is most relevant. A significant improvement of the reproductive performance in PRRS virus contaminated environments and a reduction of transplacental virus transmission after challenge was observed in vaccinated pigs. Onset of immunity: 28 days post vaccination. Duration of immunity: 24 weeks post vaccination. 3.3 CONTRAINDICATIONS Do not use in herds where the preva Read the complete document